KARE: Ketamine for reduction of Alcoholic Relapse

06 November 2018

Do you want to stop drinking alcohol?

If you are ready to stop drinking or have already done so, you may be eligible to take part in the KARE trial.

This study looks at the effects of giving a low dose intravenous injection
through the vein (Intravenous infusion) of the drug ketamine or saline solution
(which is the placebo) over 40 mins once a week for three weeks
alongside seven sessions of a talking therapy.

We have study sites in London and Exeter.

https://psychology.exeter.ac.uk/kare

Keywords

• University of Exeter
• Psychopharmacology
• London (GB)
• Exeter
• alcohol use
• alcohol research
• problematic alcohol use
• University College London

Ethical approval

This research is approved by the South West - Central Bristol Research Ethics Committee (favourable opinion given 4-Jan-2016, REC reference 15/SW/0312).

Contact researcher